SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-19-035225
Filing Date
2019-07-19
Accepted
2019-07-19 17:00:59
Documents
6
Period of Report
2019-07-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv525493_8k.htm 8-K 28163
2 EXHIBIT 1.1 tv525493_ex1-1.htm EX-1.1 216411
3 EXHIBIT 1.3 tv525493_ex1-3.htm EX-1.3 15591
4 EXHIBIT 5.1 tv525493_ex5-1.htm EX-5.1 12008
5 GRAPHIC image_002.jpg GRAPHIC 17055
6 GRAPHIC image_003.jpg GRAPHIC 17055
  Complete submission text file 0001144204-19-035225.txt   320673
Mailing Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850 240-864-2600
CASI Pharmaceuticals, Inc. (Filer) CIK: 0000895051 (see all company filings)

IRS No.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-20713 | Film No.: 19964023
SIC: 2836 Biological Products, (No Diagnostic Substances)